Clinical Trials: Trends to Watch For In Next 5 Years
Clinical trials are at the heart of medical innovation, driving the development of new treatments and therapies. As we look ahead to the next five years, several key trends are set to revolutionize the landscape of clinical trials. From technological advancements to regulatory changes, here’s a closer look at the biggest trends shaping the future […]
On Demand Webinar – Decentralized Clinical Trials and Digital Health Navigating the Opportunities and Challenges
Overview: As the healthcare industry pushes towards modernizing clinical trials, recent draft guidance from the FDA, ICH, and others aims to guide the industry in adopting decentralized clinical trials (DCT) and digital health technologies for remote data acquisition. These new approaches present a significant opportunity to transform the way clinical trials are conducted, with potential […]
FDA Draft Guidance Summary — Decentralized Clinical Trials for Drugs, Biological Products, and Devices
The US Food and Drug Administration (FDA) has released a draft guidance document on decentralized clinical trials (DCTs) for drugs, biological products, and medical devices. This guidance outlines the FDA’s recommendations for designing, executing, and evaluating these trials and provides guidance on ensuring patient safety and the accuracy of the data generated. Additionally, it includes […]